SYNOVIAL SARCOMA
Clinical trials for SYNOVIAL SARCOMA explained in plain language.
Never miss a new study
Get alerted when new SYNOVIAL SARCOMA trials appear
Sign up with your email to follow new studies for SYNOVIAL SARCOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Drug access bridge: tazemetostat rollover study offers continued treatment
Disease control CompletedThis study allowed people with certain cancers who had already benefited from the drug tazemetostat in earlier studies to keep receiving it. The main goal was to track long-term safety and side effects. Participants had already shown clinical benefit and continued treatment under…
Matched conditions: SYNOVIAL SARCOMA
Phase: PHASE1, PHASE2 • Sponsor: Epizyme, Inc. • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Scientists hunt for clues to predict sarcoma drug success
Knowledge-focused CompletedThis study aimed to find biological markers that could predict how well the drug trabectedin works in people with certain advanced soft-tissue sarcomas. Researchers collected tumor samples and blood from 29 adults before and during treatment to look for patterns. The goal was to …
Matched conditions: SYNOVIAL SARCOMA
Phase: NA • Sponsor: Institut Bergonié • Aim: Knowledge-focused
Last updated May 12, 2026 13:43 UTC